TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
Saliha EsenbogaDeniz CagdasNazli Eylem AlkanatGaye Güler TezelSibel Ersoy EvansKaan BoztugIlhan TezcanPublished in: Journal of cosmetic dermatology (2021)
The vast majority of primary immunodeficiencies (PIDs) occur due to the defects in cells originating from hematopoietic stem cells, while in some PIDs, there are defects in various genes responsible for non-leucocyte immune response such as seen in epidermodysplasia verruciformis (EV). EV caused by the mutations in TMC6, TMC8, and CIB1 genes is called "typical." "Atypical" EV may develop in patients with primary immunodeficiencies originating from hematopoietic stem cells, which include severe T-cell failure, caused by inactivating biallelic mutations of STK4, RHOH, CORO1A, ITK, TPP2, DCLRE1C, LCK, RASGRP1, or DOCK8 genes. Here, we present a family with TMC8 gene mutation leading to disseminated epidermodysplasia verruciformis including laryngeal papilloma and recurrent cutaneous squamous cell carcinomas. Typical EV with impaired local, keratinocyte-intrinsic immune response should be considered when routine immunological examinations are normal in patients presenting with clinical signs of EV. Although it is not possible to prevent EV lesions, early and appropriate surveillance for malignancy is mandatory.
Keyphrases
- stem cells
- immune response
- genome wide
- squamous cell
- bone marrow
- induced apoptosis
- genome wide identification
- public health
- bioinformatics analysis
- early onset
- toll like receptor
- cell therapy
- dendritic cells
- cell cycle arrest
- clinical practice
- mesenchymal stem cells
- gene expression
- high grade
- endoplasmic reticulum stress
- autism spectrum disorder
- signaling pathway
- cell death
- drug induced